11 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents ... (DOACS + Warfarin ... #DOAC #Dosing #Oral ... #Table #Pharmacology
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
Statins intensity, drug ... administration and missed doses ... #pharmacology #overview ... #medications #comparison ... #drugs #table
Warfarin to DOAC and DOAC to Warfarin Transitions 

Here are a couple of charts to help
for easier dosing ... DOAC's that are dosed ... <2.5, but that drug ... Anticoagulation #Pharmacology ... #Table
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... e.g. at lower doses ... #pharmacology #comparison ... #medications #dosing ... #drugs #table #
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... phosphate binding agents ... since they are not able ... levels toward the normal ... #Dosing #Pharmacology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors - Normal ... and Renal Dosing ... This drug class ... #Pharmacology # ... Diabetes #DM2 #Endocrinology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
agents preferred ... over injectable agents ... p-Aminosalicylic acid, High-dose ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... and sodium • Dosing ... 10 g QD (adjust dose ... #medications #pharmacology ... #table #comparison
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... order for the drug ... to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
agents in the acute ... of a given drug ... the timing and dosing ... of a given drug ... ticagrelor #prasugrel #pharmacology